02 August 2012 08:32

EC raises concern at Visa Europe on credit card interchange fees

Visa Europe

European regulators have formally raised concerns that consumers could be paying too much because of fees charged by Visa to process cross-border credit card transactions.

The European Commission told Visa of its concerns about "possible violations of EU antitrust rules" relating to Visa's "multilateral interchange fees" (MIFs) system, which charges retailers for the transactions they handle. 

In a supplementary statement, the Commission says that its preliminary view is that the Visa multilateral interchange fees (MIFs) for consumer credit cards violate its rules designed to stop cartels and restrictive business practices.

The EC says it thinks that MIFs "harm competition between acquiring banks, inflate the cost of payment card acceptance for merchants and ultimately increase consumer prices".

It also "doubts" that Visa's MIFs are "necessary to create efficiencies that benefit merchants and consumers" and could therefore be entitled to an exception from the rules. 

The supplementary statement is the latest stage in a lengthy battle that saw Visa slash its multilateral interchange fees for debit cards in late 2010 but refuse to back down credit cards.

Visa can now make a written reply or ask for a hearing on the issue which could see fines imposed of up to 10% of turnover imposed for antitrust breaches,

Responding to the new development, Peter Ayliffe, CEO, Visa Europe, says: "We are very disappointed that the Commission has taken such a confrontational approach and was not willing to find a solution to support investment and innovation in European payments for the benefit of European consumers and to allow European payments to compete globally." 

In May an EU court dismissed Visa rival MasterCard's challenge against an EC ruling that the firm's cross-border interchange fees for both credit and debit cards violated competition law.

Meanwhile, both card giants are facing interchange problems in the US: having agreed a $7.25 billion class action settlement with retailers earlier this month, several major merchants, including Walmart, have now come out against the plan.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
18 Oct
OMXC20
Data herunder er lavet på C20 Cap og C20 vægtet til at passe til C20 Cap i 2010 og 2011.   Siden den..
65
16 Oct
 
Jeg skriver lige det her indlæg fordi det er 5. gang som investor jeg oplever en af de her lidt stør..
56
16 Oct
 
Kære Alle   Jeg takker Jer alle for en god tid her, jeg erkender at have tabt, selvom jeg holdt mig ..
36
17 Oct
VWS
Normal 0 21 false false false DA X-NONE X-NONE ..
28
17 Oct
I:SP500
  Hvorfor aktiemarkedet ikke er blevet for dyrt   I mit indlæg vedr. aktie- og vækstkrise beskrev je..
21
16 Oct
I:SP500
  @bgadk – enig i, at en moderat inflationær politik der holder deflations-spøgelset nede, er præcis..
20
15 Oct
VWS
Hej   Jeg kan umuligt være det eneste menneske der er sygt træt af at, bankerne (Gold/Morgan), voldt..
17
20 Oct
VELO
Tvivler på at du får ret. Aktieanalytikerne siger allerede før godkendelsen en KORTSIGTET kurs på 2..
16
16 Oct
OMXC20
Med reference til mit indlæg af 10.07.2014 emne nummer 280903   Dengang i juli var der uro på marked..
16
16 Oct
PNDORA
Til dem som ikke gider trykke over på en anden side: -----------------------------------------------..
14

Tech Companies Send Criticism Along With NSA-Related Data -- Update

04/02/2014 00:06:00
By Danny Yadron Technology companies including Google Inc. and Microsoft Corp. released new figures on the amount of data requests they received from U.S. ..

U.S. Hot Stocks: Hot Stocks to Watch

03/02/2014 14:07:00
Among the companies with shares expected to actively trade in Monday's session is Herbalife Ltd. (HLF). Herbalife Ltd. (HLF) raised its fourth-quarter outl..

Pfizer Study Meets Primary Endpoints

03/02/2014 13:05:00
Pfizer Inc. (PFE) said Monday that a Phase 2 trial of its advanced breast cancer treatment met its primary endpoint. Pfizer said a study comparing the effec..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Novartis announces FDA Advisory Committee unanimously recommends approval of AIN457 (secukinumab) for patients with moderate-to-severe plaque psoriasis
2
Constellation Brands Launches Global 'Nourishing Neighbors' Initiative to Fight Hunger In Local Communities
3
NGEX ANNOUNCES POSITIVE RESULT OF PRELIMINARY ECONOMIC ASSESSMENT AND AN UPDATED MINERAL RESOURCE ESTIMATE FOR ITS LOS HELADOS P
4
Constellation Brands Announces Full Redemption of 8 3/8% Senior Notes Due 2014
5
Orion Group Interim Report January-September 2014
Euroinvestor around the globe: Euroinvestor.dk | Euroinvestor.se | Euroinvestor.no | Euroinvestor.fr | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Copyright Euroinvestor A/S 2014   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
21 October 2014 14:28:56
(UTC) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20141015.1 - EUROWEB4 - 2014-10-21 15:28:56 - 2014-10-21 14:28:56 - 1000 - Website: OKAY